{"protocolSection":{"identificationModule":{"nctId":"NCT01336153","orgStudyIdInfo":{"id":"RN89-01-117-7548"},"organization":{"fullName":"Shahid Beheshti University","class":"OTHER"},"briefTitle":"Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke"},"statusModule":{"statusVerifiedDate":"2010-12","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2009-08"},"primaryCompletionDateStruct":{"date":"2010-01","type":"ACTUAL"},"completionDateStruct":{"date":"2010-12","type":"ACTUAL"},"studyFirstSubmitDate":"2011-04-13","studyFirstSubmitQcDate":"2011-04-14","studyFirstPostDateStruct":{"date":"2011-04-15","type":"ESTIMATED"},"lastUpdateSubmitDate":"2011-04-29","lastUpdatePostDateStruct":{"date":"2011-05-02","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Mostafa Ghanei","oldOrganization":"Ministry of Health"},"leadSponsor":{"name":"Shahid Beheshti University","class":"OTHER"},"collaborators":[{"name":"Shahid Beheshti University of Medical Sciences","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"To investigate the safety and efficacy of MLC601 (NeuroAideTM) as a Traditional Chinese Medicine on motor recovery after ischemic stroke.","detailedDescription":"This is a double-blind, placebo-controlled clinical trial study on 150 patients with a recent (less than 3 month) ischemic stroke. All patients will give either MLC601 (100 patients) or placebo (50 patients), 4 capsules 3 times a day, as an add-on to standard medication of post stroke for 3 months. Motor improvement will be monitored using Fugl-Meyer Assessment FMA."},"conditionsModule":{"conditions":["Stroke"],"keywords":["Safety","Efficacy","MLC601","motor recovery"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":150,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"MLC601","type":"EXPERIMENTAL","description":"MLC601 (NeuroAideTM) is a TCM which is used extensively in China to improve recovery after stroke. It combines several herbal and animal components.","interventionNames":["Drug: MLC601"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"type":"DRUG","name":"MLC601","description":"group A (100 patients; NeuroAid 400mg, 4 capsules 3 times daily) or for 3 month","armGroupLabels":["MLC601"]},{"type":"DRUG","name":"Placebo","description":"group B (50 patients; placebo, 4 capsules 3 times daily) for 3 months","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Investigate the Safety and Efficacy of MLC601","description":"Patients showed a good tolerability to treatment and adverse events were mild and transient.","timeFrame":"18 months"}],"secondaryOutcomes":[{"measure":"Motor recovery of MLC601 in 150 Iranian Patients after Stroke","description":"Repeated measured analysis showed statistically difference in Fugl-Meyer Assessment FMA score during 12 months between two groups","timeFrame":"18 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* age between 30-72 yars,\n* \\< one month after stroke,\n* ischemic cerebral stroke,\n* signed informed consent form.\n\nExclusion Criteria:\n\n* treatment with thrombolytic after stoke,\n* ischemic stroke combined with hemorrhage, severe renal or liver failure, dementia, psychosis and history of seizure disorder, history of previous stroke, and hemoglobin level less than 10mg/dl on admission.","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"72 Years","stdAges":["ADULT","OLDER_ADULT"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}